The acquisition will help accelerate Aspirion’s investment in intelligent automation to advance operational effectiveness, recovery yield and pace of collections for its clients, according to a Sept. 12 Aspirion news release.
Infinia ML will operate as Aspirion’s research and development engine, “focusing on leap-ahead AI capabilities to drive improved financial performance for healthcare providers,” according to the release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.